Mid-Year Report — CENTER FOR REPRODUCTIVE RIGHTS for CENTER FOR REPRODUCTIVE RIGHTS (2007)

Firm

CENTER FOR REPRODUCTIVE RIGHTS

Client

CENTER FOR REPRODUCTIVE RIGHTS

Income

—

Expenses

—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Family issues/Abortion/Adoption FAM

End Shackling of Pregnant Prisoners Federal Abortion Ban Freedom of Choice Act (FOCA) H 493, GINA, proposed amendments HR 2478 Hyde Amendment, legislation to repeal Michaud Amendment, DOD authorization/appropriations bills, EC access OWH, proposed budget cuts within FDA PBA Decision, proposed legislation in response Pence Amendment, HHS authorization bill Prevention First Act, S. 21/H.R. 819 Pro FP DASPA, appointment Rush Post-Partum Mental Health Bill Senate Committee on Opportunities for Women and Girls, Title X funding Senate Committee on Sex Education, Medicaid coverage of family planning & Title X funding Title V, abstinence education funding Weldon Amendment, Title X funding & opposition to federal refusal clause Access to Legal Pharmacueticals Act CERD Letter to State Department Community Based Abstinence Education, appropriation DOC/EC Amendment

Lobbyist	Covered position, as disclosed
JANET CREPPS	N/A
LAURA E KATZIVE	N/A
NANCY NORTHUP	N/A
ROBERT RABEN	N/A
DIONNE SCOTT	N/A
NAN STRAUSS	N/A
MELISSA UPRETI	N/A

Contacted: Health & Human Services, Dept of (HHS); State, Dept of (DOS); SENATE; Treasury, Dept of; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2478 (110th), S. 21 (110th), H.R. 819 (110th)

Foreign Relations FOR

Global Gag Rule Protection Against Transmission of HIV for Women and Youth Act (PATHWAY), H.R. 1713 US Resolutions, Commission on Status of Women (CSW) session on forced/child marriages & female infanticide US support for inclusion of reproductive rights within World Bank's Strategy for Health, Nutrition & Population Results

Lobbyist	Covered position, as disclosed
JANET CREPPS	N/A
LAURA E KATZIVE	N/A
NANCY NORTHUP	N/A
ROBERT RABEN	N/A
DIONNE SCOTT	N/A
NAN STRAUSS	N/A
MELISSA UPRETI	N/A

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; State, Dept of (DOS); Treasury, Dept of; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1713 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.